Resources
The National Pharmaceutical Council (NPC) is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation.
Filter by:
Topic
Topic
- Accountable Care Organizations
- Alternative Payment Models
- Biopharmaceutical Innovation
- Bundled Payments
- Clinical Pathways
- Decision Frameworks
- Elements of Value
- Evidence for Decision Making
- Formulary/Benefit Design
- Formulary Development
- Good Practices for Evidence
- Health Care Quality Measures
- Health Spending
- Health Spend Management
- High-Deductible Health Plans
- Impact on Outcome & Spending
- Individual Treatment Effects & Personalized Access
- IRA Implementation
- Low-Value Care
- Pandemic Response
- Patient Cost Sharing
- Paying for Cures
- Pharmacy Benefit Managers (PBMs)
- Policy & Regulatory Barriers
- Real-World Data
- Real-World Evidence
- Regulatory Barriers & Challenges
- Understanding Health Spending
- Utilization Management & Step Therapy
- Value-Based Contracts
- Value-Based Insurance Design
- Value Assessment
- Value Assessment Frameworks
- Value Assessment Methods
Resource Type
Display Only
Showing 1216 Results
#TBT: Enrollment Deadline & the Role of Rx in Health Exchanges
As part of our “Throwback Thursday” blog series, we’re taking a look at a research topic that’s currently in the news and tagging it with previous research, videos or commentaries in a…
CER Collaborative Rolls Out New Resources to Aid Formulary Decision-Making
A newly published series of peer-reviewed articles developed by the CER Collaborative will help formulary decision-makers more effectively evaluate comparative effectiveness research (CER) studies…
CER Collaborative: Series of Questionnaires to Guide Decision-makers in Reviewing Studies
Three peer-reviewed articles offer important guidance to aid formulary decision-makers in evaluating certain types of comparative effectiveness research (CER) studies.
The New Pharmaceutical Paradigm: Capturing Value, Improving Access, and Maximizing Outcomes
Dr. Chuck Shih, NPC’s fellow in comparative effectiveness research, discusses how the use and management of pharmaceuticals are being integrated into new care delivery and payment models in a column…
Practice-Based Research Networks: Will Their Promise Become Reality?
Practice-based research networks (PBRNs) could provide “real-world” answers to health care treatment questions, but researchers must first address a variety of evidence, regulatory and communications…
#TBT: Alzheimer’s & Access to Health Information
As part of our “Throwback Thursday” blog series, we’re taking a look at a research topic that’s currently in the news and tagging it with previous research, videos or commentaries in a…
NPC Asks CMS to Consider Patients’ Individual Treatment Effects In Part D Rulemaking
The National Pharmaceutical Council (NPC) today asked the Centers for Medicare and Medicaid Services (CMS) to consider maintaining “protected classes” designations under its prescription drug benefit…
NPC Comments on CMS' Proposed Changes to Protected Classes
NPC commented on a proposed rule that would revise the prescription drug benefit program (Part D) regulations (as well as other CMS programs and policies) to implement revised statutory requirements.
ICYMI: Articles of Interest (February 2014)
It’s nearly impossible to stay on top of all the articles you need to read when thousands of peer-reviewed journal articles are published each month. Below are a handful of articles concerning…
#TBT: Need Evidence to Inform Health Decisions? Do it GRACEfully with our Checklist
As part of our “Throwback Thursday” blog series, we’re taking a look at a research topic that’s currently in the news and tagging it with previous research, videos or commentaries in a…
The GRACE Checklist for Rating the Quality of Observational Studies of Comparative Effectiveness: A Tale of Hope and Caution
With the growing demand for information about comparative effectiveness and questions about the quality of research that will support future health care decision-making, a group of researchers…
#TBT: Bob Costas, Presenteeism and Its Impact on Productivity
As part of our “Throwback Thursday” blog series, we’re taking a look at a research topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way…
ICYMI: CER Articles of Interest
With thousands of peer-reviewed journal articles published each month, it’s nearly impossible to stay on top of all the articles you need to read. That’s why we’ve highlighted a handful of articles…
How Can Big Data Improve Innovation and Health Care?
The use of “big data” is growing rapidly in health-related research, but how can it be leveraged to improve innovation and health care?Join experts from the Food and Drug Administration (FDA),…
ACOs and Medication Management
Recent research has shown that many accountable care organizations (ACOs) have room for improvement, with a key finding being the potential value of expanding the role of pharmacists in the ACO…
#TBT: Pragmatic Clinical Trials
After deciding that we didn’t want to post embarrassing photos on Instagram, we opted instead to bring the “Throwback Thursday” concept to our blog. Starting today, on every other Thursday we’re…